| 09th week of 2021 patent applcation highlights part 11 |
| Patent application number | Title | Published |
|---|
| 20210060097 | SERPIN PRODUCTION | 2021-03-04 |
| 20210060098 | Use of Inosine for the Treatment of T-Reg Deficiency | 2021-03-04 |
| 20210060099 | NUTRITIONAL SUPPLEMENTS AND METHODS OF NUTRITIONAL SUPPLEMENTATION AFFECTING MICROBIOME METABOLISM | 2021-03-04 |
| 20210060100 | PHAGE THERAPY OF E COLI INFECTIONS | 2021-03-04 |
| 20210060101 | TROPIC CELL BASED VIROTHERAPY FOR THE TREATMENT OF CANCER | 2021-03-04 |
| 20210060102 | CANCER THERAPY WITH A PARVOVIRUS COMBINED WITH BEVACIZUMAB | 2021-03-04 |
| 20210060103 | ONCOLYTIC VIRUS IMPROVED IN SAFETY AND ANTICANCER EFFECT | 2021-03-04 |
| 20210060104 | ANTIOXIDANT COMPOSITION COMPRISING SARGASSUM SERRATIFOLIUM EXTRACT OR FRACTION THEREOF AS ACTIVE INGREDIENT | 2021-03-04 |
| 20210060105 | GINKGO BILOBA EXTRACT COMPOSITE FORMULATION AND USE OF THE SAME | 2021-03-04 |
| 20210060106 | METHOD FOR OBTAINING SAPONINS FROM PLANTS | 2021-03-04 |
| 20210060107 | COMPOSITION FOR REDUCING DETERIORATION OF MENTAL FUNCTION | 2021-03-04 |
| 20210060108 | INULA HELENIUM EXTRACTS FOR TREATING AND PREVENTING POLLUTION RELATED DAMAGE | 2021-03-04 |
| 20210060109 | NATURAL COMBINATION PRODUCTS AND METHODS FOR REGULATION OF KIDNEY AND EXCRETORY SYSTEM FUNCTION | 2021-03-04 |
| 20210060110 | ANTISEPTIC COMPOSITONS AND METHODS OF USE | 2021-03-04 |
| 20210060111 | NUTRITIONAL SUPPLEMENTS AND METHODS OF SUPPLEMENTATION AFFECTING THE ENDOCANNABINOID SYSTEM | 2021-03-04 |
| 20210060112 | NUTRITIONAL SUPPLEMENTS AND METHODS OF NUTRITIONAL SUPPLEMENTATION AFFECTING MOOD AND FOCUS IN CHILDREN | 2021-03-04 |
| 20210060113 | PAIN-RELIEVING COMPOSITION | 2021-03-04 |
| 20210060114 | METHOD OF INCREASING OMEGA-3 CONTENT IN POULTRY | 2021-03-04 |
| 20210060115 | SUGAR CANE EXTRACTS FOR USE IN ANIMAL FEEDS | 2021-03-04 |
| 20210060116 | PEPTIDES AND METHODS FOR TREATMENT OF NEURODEGENERATIVE DISEASES | 2021-03-04 |
| 20210060117 | ZINC ACTIVATED THYMULIN AND METHODS OF PREPARATION AND ADMINISTRATION | 2021-03-04 |
| 20210060118 | THERAPEUTIC HOMODIMER AND USES THEREOF | 2021-03-04 |
| 20210060119 | OXYTOCIN COMPOSITIONS FOR TREATMENT OF TINNITUS | 2021-03-04 |
| 20210060121 | NOVEL ANTIBIOTICS AND METHODS OF USING THEM | 2021-03-04 |
| 20210060122 | Method For Treating Cerebral Stroke | 2021-03-04 |
| 20210060123 | THERAPEUTIC USE OF P75NTR NEUROTROPHIN BINDING PROTEIN | 2021-03-04 |
| 20210060124 | METHODS AND COMPOSITIONS FOR TREATING HUNTINGTON'S DISEASE | 2021-03-04 |
| 20210060125 | METHOD AND USE OF PnPP-19 FOR PREVENTING AND TREATING EYE DISEASES | 2021-03-04 |
| 20210060126 | MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) COMPOSITIONS AND METHODS OF USE THEREOF | 2021-03-04 |
| 20210060127 | USE OF THE BASIC FORM OF RECOMBINANT HUMAN ERYTHROPOIETIN IN THE TREATMENT OF A PATIENTS WITH SPINOCEREBELLAR ATAXIA WITH CAG REPEAT MUTATIONS | 2021-03-04 |
| 20210060128 | METHOD FOR ACHIEVING DESIRED GLIAL GROWTH FACTOR 2 PLASMA LEVELS | 2021-03-04 |
| 20210060129 | IGG4 FC FRAGMENT COMPRISING MODIFIED HINGE REGION | 2021-03-04 |
| 20210060130 | PHARMACEUTICAL COMPOSITIONS AND USE THEREOF FOR RELIEVING ANTICANCER DRUG RESISTANCE AND ENHANCING SENSITIVITY OF ANTICANCER DRUG | 2021-03-04 |
| 20210060131 | INTRACELLULAR IL-1 ALPHA PEPTIDE METHODS AND COMPOSITIONS | 2021-03-04 |
| 20210060132 | Process for the Preparation of Insulin-Zinc Complexes | 2021-03-04 |
| 20210060133 | RAPID-ACTING INSULIN FORMULATION COMPRISING A SUBSTITUTED ANIONIC COMPOUND | 2021-03-04 |
| 20210060134 | NANOSPHERES FOR BONE FRACTURE | 2021-03-04 |
| 20210060135 | WOUND TREATMENT CONTAINING COLLAGEN AND A GELATIN-REDUCING AGENT, AND METHOD FOR PROMOTING WOUND HEALING | 2021-03-04 |
| 20210060136 | USE OF HEMOGLOBIN FROM ANNELIDS AS BACTERICIDE, IN PARTICULAR FOR PREVENTING AND/OR TREATING A PERIODONTAL DISEASE | 2021-03-04 |
| 20210060137 | NUTRIENT COMPOSITIONS HAVING ENHANCED BIOAVAILABILITY | 2021-03-04 |
| 20210060138 | CRISPR and LASER ART Eliminates HIV | 2021-03-04 |
| 20210060139 | ALKALINE PHOSPHATASE AGENTS FOR TREATMENT OF NEURODEVELOPMENTAL DISORDERS | 2021-03-04 |
| 20210060140 | SEQUENCE SPECIFIC ANTIMICROBIALS | 2021-03-04 |
| 20210060141 | SEQUENCE SPECIFIC ANTIMICROBIALS | 2021-03-04 |
| 20210060142 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS | 2021-03-04 |
| 20210060143 | THERMOSENSITIVE HYDROGEL COLLAGENASE FORMULATIONS | 2021-03-04 |
| 20210060144 | NEUROTOXIN COMPOSITIONS FOR USE IN TREATING HEADACHE | 2021-03-04 |
| 20210060145 | DENDRITIC CELL VACCINATION SEQUENTIAL TO CHEMOTHERAPY | 2021-03-04 |
| 20210060146 | DENDRITIC CELL VACCINATION IN PARALLEL TO CHEMOTHERAPY | 2021-03-04 |
| 20210060147 | ANTI-CANCER PLANT VIRUS PARTICLES LINKED TO HER2 ANTIGENS | 2021-03-04 |
| 20210060148 | COMPOSITIONS COMPRISING ENGINEERED EMBRYONIC STEM CELL-DERIVED EXOSOMES AND METHOD OF USE THEREFOR | 2021-03-04 |
| 20210060149 | COMPOUNDS INCLUDING A MUTANT KRAS SEQUENCE AND A LIPID AND USES THEREOF | 2021-03-04 |
| 20210060150 | NOVEL ADENOVIRUS | 2021-03-04 |
| 20210060151 | REGIMENS FOR IMMUNISATION WITH MENINGOCOCCAL CONJUGATES | 2021-03-04 |
| 20210060152 | MULTIPLE MOSQUITO-BORNE FLAVIVIRUS VACCINE AND USE THEREOF IN INDUCING NEUTRALIZING ANTIBODIES | 2021-03-04 |
| 20210060153 | METHOD FOR PREPARING INFLUENZA WORKING VIRUS SEED STOCK, METHOD FOR PREPARING INFLUENZA VACCINE USING SAME SEED STOCK, AND VIRUS SEED STOCK PREPARED BY SAME METHOD | 2021-03-04 |
| 20210060154 | VACCINE COMPOSITION AND METHOD OF PREVENTING PORCINE EPIDEMIC DIARRHEA VIRUS INFECTION IN SWINE | 2021-03-04 |
| 20210060155 | MVA VECTORS FOR EXPRESSING MULTIPLE CYTOMEGALOVIRUS (CMV) ANTIGENS AND USE THEREOF | 2021-03-04 |
| 20210060156 | IMMUNOSTIMULATORY COMPOSITIONS | 2021-03-04 |
| 20210060157 | ANTIBODIES THAT BIND HUMAN C6 AND USES THEREOF | 2021-03-04 |
| 20210060158 | AGONIST OF ARYL HYDROCARBON RECEPTOR FOR USE IN CANCER COMBINATION THERAPY | 2021-03-04 |
| 20210060160 | TREATMENT FOR BONE DISEASES | 2021-03-04 |
| 20210060161 | TREATMENT OF OVARIAN CANCER IN PATIENTS WITH ASCITES USING A SPECIFIC BINDING AGENT OF HUMAN ANGIOPOIETIN-2 IN COMBINATION WITH A TAXANE | 2021-03-04 |
| 20210060162 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF AN INFLAMMATORY BOWEL DISEASE | 2021-03-04 |
| 20210060163 | VACCINE FOR TREATMENT OF CANCER AND METHOD OF MAKING BY STRESS REPROGRAMMING | 2021-03-04 |
| 20210060164 | NONINVASIVE DEEP BRAIN STIMULATION (DBS) USING X-RAY-EXCITED OPTICAL LUMINESCENT (XEOL) NANOMATERIALS (NANOSCINTILLATORS) | 2021-03-04 |
| 20210060165 | Light-Controlled Antibacterial Agent Composed of Linear Cationic Oligopeptide and Multi-arm B-Cyclodextrin | 2021-03-04 |
| 20210060166 | Method for the preparation of a 1,7-bis (4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione system in polysorbates for the formation of micelles in an aqueous medium aimed at the properties of the bioavailability of curcuminoids | 2021-03-04 |
| 20210060167 | CARBON MONOXIDE-RELEASING MOLECULE CONJUGATES AND RELATED COMPOSITIONS AND METHODS | 2021-03-04 |
| 20210060168 | ASIALOGLYCOPROTEIN RECEPTOR MEDIATED DELIVERY OF THERAPEUTICALLY ACTIVE CONJUGATES | 2021-03-04 |
| 20210060169 | IL-2 VARIANT | 2021-03-04 |
| 20210060170 | PHOTODYNAMIC THERAPY COMPOSITION | 2021-03-04 |
| 20210060171 | ALBUMIN BINDING PEPTIDE-DRUG (AIBIPED) CONJUGATES AND METHODS OF MAKING AND USING SAME | 2021-03-04 |
| 20210060172 | THERAPEUTIC DENDRIMERS | 2021-03-04 |
| 20210060173 | PSMA TARGETED CONJUGATE COMPOUNDS AND USES THEREOF | 2021-03-04 |
| 20210060174 | PROTEIN DELIVERY TO MEMBRANES | 2021-03-04 |
| 20210060175 | METHODS OF IMMUNOSTIMULATION WITH COMPLEXES OF RNA AND CATIONIC CARRIERS | 2021-03-04 |
| 20210060176 | METHODS AND COMPOSITIONS FOR TREATMENT OF OCULAR DISORDERS AND BLINDING DISEASES | 2021-03-04 |
| 20210060177 | LIPID NANOPARTICLE COMPOSITIONS AND METHODS FOR MRNA DELIVERY | 2021-03-04 |
| 20210060178 | AAV/XBP1S-HA VIRUS, GENE THERAPY METHOD AND USE THEREOF IN THE OPTIMISATION AND IMPROVEMENT OF LEARNING, MEMORY AND COGNITIVE CAPACITIES | 2021-03-04 |
| 20210060179 | MODULATION OF LIVER GENES | 2021-03-04 |
| 20210060180 | RECOMBINOGENIC NUCLEIC ACID STRANDS IN SITU | 2021-03-04 |
| 20210060181 | NUCLEIC ACID COMPRISING OR CODING FOR A HISTONE STEM-LOOP AND A POLY(A) SEQUENCE OR A POLYADENYLATION SIGNAL FOR INCREASING THE EXPRESSION OF AN ENCODED THERAPEUTIC PROTEIN | 2021-03-04 |
| 20210060182 | RNA TRANSCRIPTION VECTOR AND USES THEREOF | 2021-03-04 |
| 20210060183 | REACTIVE MULTI-ARM POLYMERS HAVING BRANCHED END GROUPS | 2021-03-04 |
| 20210060184 | METHODS AND COMPOSITIONS FOR DEUTERATED BIOLOGICS | 2021-03-04 |
| 20210060185 | PROTEASE SENSITIVE GVPC AND RELATED GAS VESICLE GENE CLUSTERS, EXPRESSION SYSTEMS, CONSTRUCTS, VECTORS, GENETIC CIRCUITS, CELLS, COMPOSITIONS, METHODS AND SYSTEMS FOR CONTRAST-ENHANCED IMAGING | 2021-03-04 |
| 20210060186 | 2-[5-(IMIDAZOL-1-YLMETHYL)PYRIDIN-3-YL]BENZIMIDAZOLE DERIVATIVE COMPOUND, AND MEDICAMENT INCLUDING SAME | 2021-03-04 |
| 20210060187 | PROBES FOR IMAGING HUNTINGTIN PROTEIN | 2021-03-04 |
| 20210060188 | TCO CONJUGATES AND METHODS FOR DELIVERY OF THERAPEUTIC AGENTS | 2021-03-04 |
| 20210060189 | RADIOPHARMACEUTICAL COMPOSITIONS | 2021-03-04 |
| 20210060190 | RESIDUALIZING LINKERS AND USES THEREOF | 2021-03-04 |
| 20210060191 | DISINFECTION APPARATUS FOR A VEHICLE USING ULTRAVIOLET RADIATION | 2021-03-04 |
| 20210060192 | ANTIMICROBIAL DEVICE USING ULTRAVIOLET LIGHT | 2021-03-04 |
| 20210060193 | STERILIZATION APPARATUS | 2021-03-04 |
| 20210060194 | ELECTROCHEMICAL DEVICE FOR RELEASING IONS | 2021-03-04 |
| 20210060195 | METHOD FOR THE SANITIZING TREATMENT OF A TEXTILE PRODUCT | 2021-03-04 |
| 20210060196 | Systems and Methods for the Production of Gelled Sanitizer Compositions Under Extensional Flow Conditions | 2021-03-04 |
| 20210060197 | METHODS AND SYSTEMS FOR FLUSHING A MEDICAL GAS FLOW SYSTEM | 2021-03-04 |
| 20210060198 | METHOD AND APPARATUS FOR DISINFECTION | 2021-03-04 |
